Candel Therapeutics Competitors and Similar CompaniesClear all
Candel Therapeutics's competitors and similar companies include ESSA Pharma, Nektar Therapeutics, Oncopeptides and PLIVA.
 Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. |  ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer. |  PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products. | |||
Founding Date | Founding Date 1999 | Founding Date 2009 | Founding Date 1990 | Founding Date 2000 | Founding Date 1921 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Needham, US HQ | Locations Vancouver, CA HQ Houston, US South San Francisco, US | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US | Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS |
Employees | Employees 50 | Employees 35 | Employees 61821% increase | Employees 80 | Employees 1,685 |
Valuation ($) | Valuation ($) 176.8 m | Valuation ($) 240 m | Valuation ($) 233.8 m | Valuation ($) 42.4 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) kr71.1m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($38.2m) (FY, 2025) | Net income ($28.5m) (FY, 2024) | Net income ($164.1m) (FY, 2025) | Net income (kr249.6m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 64.6m | Total funding raised $ 74.1m | Total funding raised $ 45m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ESSA Pharma
HQ
Vancouver, CA
Employees
35
ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer.
View company
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View company
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View companyPLIVA
HQ
Zagreb, HR
PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
View company